Journal article
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial
Microneedle patches provide an alternative to conventional needle-and-syringe immunisation, and potentially offer improved immunogenicity, simplicity, cost-effectiveness, acceptability, and safety. We describe safety, immunogenicity, and acceptability of the first-in-man study on single, dissolvable microneedle patch vaccination against influenza.
Languages
- English
Publication year
2017
Publisher
Elsevier
Journal
The Lancet
Type
Journal article
Categories
- Vaccines & delivery devices
Diseases
- Influenza
Tags
- Injection safety